The MMRF Blog - Multiple Myeloma Research Foundation

The MMRF Blog

MMRF Convenes Top Minds in Cancer at Immune Therapy Summit in Boston

Held in Boston, Massachusetts, the MMRF Accelerating the Next Generation of Immune Treatments in Cancer Summit convened top experts from oncology, academia, foundations and the FDA in order to exchange knowledge and insights in immuno-oncology. READ MORE

Posted: May 01, 2017

Proteasome inhibitors

Myeloma cells generate lots of additional proteins, like M proteins, that aren’t useful to the body. One way to target myeloma cells is to use these extra, “garbage” proteins to kill them. When too much garbage builds up in a cell, it dies. Proteasome inhibitors are a type of drug that prevents proteasomes, the garbage disposal system of the cell, from chewing up excess proteins. READ MORE

Posted: April 25, 2017

Finding the right specialist and treatment center

Selecting a specialist and a treatment center are among the most important decisions you have to make as an individual with multiple myeloma (MM). Various factors—such as your diagnosis, location, insurance coverage, travel options, and other preferences—may influence this decision. READ MORE

Posted: April 25, 2017

Page 6 of 87« First...45678...203040...Last »